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ABSTRACT: Ten new dolabrane-type diterpenoids, notolutesins A−J (1−10), were isolated from the Chinese liverwort
Notoscyphus lutescens, along with four known compounds. The structures of the new compounds were established on the basis of
extensive spectroscopic data, and that of 1 was confirmed by single-crystal X-ray crystallography. The absolute configuration of 1
was determined by comparing its experimental and calculated electronic circular dichroism spectra. All of the isolates were
evaluated for their cytotoxicity against a small panel of human cancer cell lines, and compound 1 exhibited an IC50 value of 6.2
μM against the PC3 human prostate cancer cell line.
L iverworts (Hepaticae) are well known to producelipophilic mono-, sesqui-, and diterpenoids, as well as
aromatic compounds, of which many exhibit a variety of
biological activities.1 Species belonging to the family
Jungermanniaceae are rich sources of labdane-, kaurane-, and
clerodane-type diterpenoids.2 Over the past few decades,
chemical studies on the family Jungermanniaceae have focused
mainly on the genus Jungermannia,3,4 while no phytochemical
investigation has been reported on species of the genus
Notoscyphus, due to difficulties concerning their collection and
taxonomy.
In the course of an ongoing search for new bioactive
substances from the Chinese liverworts,5−9 the autochthonal
liverwort Notoscyphus lutescens, collected from Mount Dawei,
Yunnan Province, People’s Republic of China, in April 2012,
was investigated phytochemically. Ten new dolabrane-type
diterpenoids, notolutesins A−J (1−10), together with four
known diterpenoids, ent-trans-communic acid,10 ent-trans-
communol,11 15,16-bis-nor-13-oxo-8(17),11(E)-labdadien-18-
ol,12 and (−)-pimara-9(11),15-dien-19-ol,13 were obtained.
This is the first isolation of dolabrane-type diterpenoids from
the family Jungermanniaceae. All of the structures were
elucidated based on extensive spectroscopic data analyses,
with single-crystal X-ray diffraction analysis performed to
confirm the structure of 1. The cytotoxic activity of the
isolated compounds was tested against five human cancer cell
lines. Details of the isolation, structure elucidation, and
cytotoxic activities of the compounds obtained are described
herein.
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■ RESULTS AND DISCUSSION
Notolutesin A (1) was obtained as colorless needles (CHCl3).
It gave a molecular formula of C20H28O3, as deduced from the
pseudomolecular ion peak at m/z 334.2380 [M + NH4]
+ (calcd
334.2377), requiring seven indices of hydrogen deficiency. The
IR spectrum of 1 exhibited absorption bands at 3483 and 1758
cm−1, accounting for the presence of OH and CO groups,
respectively. The 1H NMR spectrum (Table 1) of 1 displayed
resonances for two tertiary methyls [δH 1.01 (s, H3-17) and
0.88 (s, H3-20)], an oxygenated methylene [δH 4.49 (d, J = 8.4
Hz, Ha-19) and 3.83 (d, J = 8.4 Hz, Hb-19)], an oxygenated
methine [δH 4.45 (br t, H-2)], a monosubstituted double bond
[δH 5.80 (dd, J = 17.4, 10.8 Hz, H-15), 4.93 (d, J = 17.4 Hz,
Ha-16), and 4.87 (d, J = 10.8 Hz, Hb-16)], and an olefinic
proton at δH 6.85 (br s, H-3). The
13C NMR data (Table 3)
and HSQC spectrum denoted the presence of 20 resonances
for two methyls, seven sp3 methylenes, of which one was
oxygenated [δC 78.8 (C-19)], three sp
3 methines, of which one
was oxygenated [δC 65.0 (C-2)], three sp
3 quaternary carbons,
four olefinic carbons [δC 109.3 (C-16), 135.6 (C-4), 138.0 (C-
3), and 150.7 (C-15)], and one lactone carbonyl carbon [δC
170.2 (C-18)]. The aforementioned data indicated the
characteristic of a dolabrane-type diterpenoid skeleton and a
structure related to dolabradiene14,15 for 1. The 1H−1H COSY
data (Figure 1) of 1 revealed the presence of four isolated spin
systems: C-10(H)−C-1(H2)−C-2(H)−C-3(H), C-6(H2)−C-
7(H2)−C-8(H), C-11(H2)−C-12(H2), and C-15(H)−C-
16(H2). On the basis of the HMBC correlations (Figure 1)
from H2-19 to C-4, C-5, C-6, and C-10, from H3-20 to C-8, C-
9, C-10, and C-11, and from H3-17 to C-12, C-13, C-14, and C-
15, the 6/6/6 tricyclic core of the diterpenoid with 9,13-
dimethyl and 2-oxygenated substitutions could be elucidated.
The γ-lactone ring was established from the HMBC
correlations of H2-19/C-18 and H-3/C-18. Thus, the gross
structure of 1 with a four-ring system was established.
The relative configurations of 1 were determined by
analyzing its NOESY data (Figure 2). NOE correlations of
H-19b/H-10/H-8/H3-17 suggested that all of these are cofacial,
and they were assigned arbitrarily as β-oriented. In addition, H-
Table 1. 1H NMR Spectroscopic Data for Compounds 1−5a
position 1 2 3 4 5
1a 1.95 (ddd, 12.6, 6.6, 4.8) 2.04 (ddd, 13.2, 9.6, 4.8) 2.03 (ddd, 13.2, 9.6, 4.2) 1.70 (dd, 13.2, 7.8) 5.78 (m)
1b 1.69 (m) 1.15 (m) 1.15 (m) 1.46 (m)
2a 4.45 (br t) 4.52 (t, 4.8) 4.51 (t, 4.8) 2.18 (dt, 18.6, 4.8) 6.02 (dd, 15.0, 5.4)
2b 2.06 (m)
3 6.85 (br s) 6.39 (d, 5.4) 6.39 (d, 6.0) 5.54 (br s) 5.81 (d, 5.4)
6a 1.42 (m, H-α) 1.32 (m, H-α) 1.32 (m, H-α) 1.43 (m, H-α) 1.47 (td, 13.2, 4.2)
6b 1.68 (m, H-β) 2.48 (d, 7.8, H-β) 2.52 (d, 11.4, H-β) 1.80 (m, H-β) 2.14 (dt, 14.4, 3.0)
7a 1.67 (m) 1.28 (m) 1.34 (m) 1.43 (m) 1.27 (m)
7b 1.24 (m) 1.18 (m) 1.20 (m) 1.18 (m) 1.16 (m)
8 1.32 (m) 1.37 (m) 1.37 (m) 1.34 (m) 1.33 (m)
10 1.60 (t, 7.2) 1.25 (m) 1.25 (m) 1.19 (m) 1.61 (d, 6.0)
11a 1.65 (m) 1.35 (m) 1.35 (m) 1.60 (dd, 12.6, 3.0) 1.53 (dt, 13.2, 3.0, H-α)
11b 1.27 (m) 1.27 (m) 1.27 (m) 1.06 (dd, 12.6, 4.2) 1.24 (m, H-β)
12a 1.51 (td, 13.8, 4.2) 1.46 (td, 14.4, 4.2) 1.46 (td, 15.0, 4.2) 1.58 (dd, 15.0, 4.2, H-α) 1.20 (m)
12b 1.22 (m) 1.17 (m) 1.17 (m) 1.21 (m, H-β) 1.14 (m)
14a 1.29 (m) 1.31 (m) 1.30 (m) 1.33 (m) 1.31 (m)
14b 1.20 (m) 1.05 (td, 13.2, 2.4) 1.05 (d, 13.2) 0.97 (dd, 9.6, 1.8) 0.99 (dd, 12.0, 2.0)
15 5.80 (dd, 17.4, 10.8) 5.78 (dd, 17.4, 10.8) 5.78 (dd, 17.4, 10.8) 5.81 (dd, 17.4, 10.8) 5.78 (m)
16a 4.93 (d, 17.4) 4.90 (d, 17.4) 4.90 (d, 17.4) 4.91 (dd, 17.4, 1.2) 4.89 (dd, 17.4, 1.2)
16b 4.87 (d, 10.8) 4.84 (d, 10.8) 4.84 (d, 10.8) 4.84 (dd, 10.8, 1.2) 4.82 (dd, 10.8, 1.2)
17 1.01 (s) 1.03 (s) 1.03 (s) 1.02 (s) 1.03 (s)
18 4.26 (s) 4.36 (s) 4.09 (s) 4.25 (s)
19a 4.49 (d, 8.4) 4.25 (d, 11.4) 4.25 (d, 10.8) 1.09 (s) 1.06 (s)
19b 3.83 (d, 8.4) 4.09 (d, 11.4) 4.08 (d, 10.8)
20 0.88 (s) 0.42 (s) 0.42 (s) 0.75 (s) 0.73 (s)
21a 3.29 (s) 3.71 (quintet, 7.2)
21b 3.40 (quintet, 7.2)
22 1.12 (t, 7.2)
aRecorded at 600 MHz in CDCl3. Chemical shifts (δ) are expressed in ppm, and J values are presented in Hz.
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6α and H-6β were determined by NOE correlations with H3-20
and H-19a, respectively. NOEs observed between H3-20 and H-
2 supported the α-orientation of H-2. The conclusions stated
above were confirmed by a single-crystal X-ray crystallography
study (Figure 3). Thus, the structure and relative configuration
of 1 were elucidated as shown.
Notolutesin B (2) was assigned the molecular formula
C21H32O3, based on its
13C NMR data and HRESIMS,
indicating the presence of one more carbon atom than 1,
which was consistent with the presence of an additional
oxygenated methyl [δH 3.29 (s, H3-21); δC 55.0 (C-21)] in 2.
Furthermore, the 1H and 13C NMR data (Tables 1 and 3)
Table 2. 1H NMR Spectroscopic Data for Compounds 6−10a
position 6 7 8 9 10
1a 7.31 (d, 6.6) 2.15 (ddd, 13.2, 9.6, 4.2) 2.43 (dd, 14.4, 8.4) 2.65 (d, 18.6, H-α) 2.62 (d, 18.6, H-α)
1b 1.17 (m) 1.92 (ddd, 15.0, 9.6, 6.6) 2.75 (dd, 18.6, 6.6, H-β) 2.72 (dd, 18.6, 6.6, H-β)
2a 7.20 (t, 7.8) 4.45 (t, 4.8) 4.72 (t, 6.6)
2b
3 7.24 (d, 6.6) 6.37 (d, 5.4) 6.54 (br s) 6.19 (s) 5.84 (s)
6a 2.88 (m) 2.04 (dt, 13.8, 3.0) 1.23 (m, H-α) 2.04 (d, 15.0) 2.19 (dt, 14.4, 3.0)
6b 1.22 (m) 3.16 (d, 14.4, H-β) 1.34 (m) 1.31 (m)
7a 1.70 (m) 1.32 (m) 1.07 (d, 14.4) 1.16 (m) 1.16 (m)
7b 1.60 (m) 1.18 (m) 0.97 (m) 1.00 (m) 1.13 (m)
8 1.82 (tt, 12.6, 3.0) 1.38 (m) 1.33 (m) 1.33 (m) 1.38 (m)
10 1.37 (m) 1.40 (m) 1.67 (m) 1.67 (m)
11a 2.12 (dt, 12.6, 3.0, H-α) 1.28 (m, H-α) 1.70 (d, 12.6) 1.69 (m) 1.69 (m)
11b 1.64 (m, H-β) 1.40 (m, H-β) 1.17 (d, 13.8) 1.09 (td, 13.2, 3.0) 1.09 (td, 13.2, 4.2)
12a 1.72 (m) 1.47 (td, 14.4, 3.6) 1.49 (td, 13.8, 3.0) 1.52 (td, 14.4, 3.0) 1.52 (td, 14.4, 4.2)
12b 1.42 (dq, 13.2, 3.0) 1.18 (m) 1.22 (m) 1.22 (m) 1.22 (m)
14a 1.48 (t, 13.2) 1.30 (m) 1.36 (m) 1.40 (m) 1.33 (m)
14b 1.23 (dt, 13.8, 3.0) 1.02 (m) 0.99 (m) 1.18 (m) 1.00 (d, 12.6)
15 5.88 (dd, 17.4, 10.8) 5.79 (dd, 17.4, 10.8) 5.78 (dd, 17.4, 10.8) 5.78 (dd, 17.4, 10.8) 5.78 (dd, 17.4, 10.8)
16a 4.98 (dd, 17.4, 1.2) 4.90 (d, 17.4) 4.90 (d, 17.4) 4.90 (d, 17.4) 4.90 (d, 17.4)
16b 4.90 (dd, 10.8, 1.2) 4.84 (d, 10.8) 4.83 (d, 10.8) 4.84 (d, 10.8) 4.84 (d, 10.8)
17 1.03 (s) 1.03 (s) 1.01 (s) 1.02 (s) 1.02 (s)
18 4.68 (br s) 4.39 (s) 9.64 (s) 4.39 (s) 1.96 (s)
19a 3.35 (d, 6.6) 1.28 (s) 1.32 (s) 1.25 (s)
19b 2.90 (d, 6.6)
20 1.06 (s) 0.45 (s) 0.74 (s) 0.63 (s) 0.63 (s)
aRecorded at 600 MHz in CDCl3. Chemical shifts (δ) are expressed in ppm, and J values are presented in Hz.
Table 3. 13C NMR Spectroscopic Data (δ) for Compounds 1−10a
position 1 2 3 4 5 6 7 8 9 10
1 32.1 t 29.1 t 29.1 t 17.7 t 126.7 d 124.5 d 29.6 t 28.5 t 35.2 t 35.3 t
2 65.0 d 67.8 d 67.8 d 26.8 t 124.7 d 125.8 d 67.3 d 65.7 d 199.0 s 199.2 s
3 138.0 d 130.5 d 131.1 d 122.2 d 120.4 d 124.9 d 126.2 d 152.9 d 124.3 d 128.6 d
4 135.6 s 143.2 s 143.2 s 147.8 s 146.1 s 133.8 s 146.6 s 149.1 s 169.0 s 168.7 s
5 43.3 s 44.0 s 44.0 s 38.3 s 36.6 s 138.8 s 39.4 s 37.4 s 38.4 s 39.7 s
6 25.3 t 28.8 t 28.9 t 36.9 t 35.1 t 25.4 t 28.3 t 35.5 t 36.3 t 37.4 t
7 24.3 t 27.2 t 27.3 t 25.8 t 27.5 t 25.6 t 27.5 t 27.1 t 27.3 t 27.1 t
8 38.0 d 41.3 d 41.3 d 42.4 d 41.2 d 36.3 d 41.6 d 41.9 d 41.7 d 41.7 d
9 35.9 s 36.5 s 36.5 s 37.0 s 38.9 s 37.1 s 36.7 s 37.7 s 38.6 s 38.4 s
10 45.5 d 45.2 d 45.2 d 54.0 d 55.2 d 148.6 s 48.4 d 56.4 d 55.7 d 55.0 d
11 34.3 t 33.9 t 33.9 t 35.1 t 33.7 t 33.9 t 33.6 t 35.8 t 34.2 t 34.2 t
12 31.9 t 31.5 t 31.6 t 32.1 t 31.6 t 32.9 t 31.6 t 31.8 t 31.7 t 31.8 t
13 36.4 s 36.5 s 36.6 s 36.6 s 36.8 s 36.5 s 36.8 s 36.4 s 36.4 s 36.3 s
14 39.7 t 39.1 t 39.2 t 39.1 t 39.5 t 39.7 t 39.2 t 39.0 t 39.0 t 39.0 t
15 150.7 d 151.1 d 151.2 d 151.5 d 151.5 d 151.8 d 151.2 d 151.2 d 150.9 d 151.0 d
16 109.3 t 109.0 t 109.1 t 108.7 t 108.7 t 109.1 t 108.9 t 108.9 t 109.1 t 109.1 t
17 22.7 q 23.1 q 23.1 q 23.2 q 23.0 q 22.9 q 23.1 q 23.1 q 23.2 q 23.2 q
18 170.2 s 106.6 d 105.0 d 63.1 t 63.7 t 63.7 t 61.7 t 194.9 d 61.8 t 21.0 q
19 78.8 t 62.0 t 62.0 t 22.2 q 31.6 q 75.5 t 34.5 q 33.5 q 32.4 q
20 14.2 q 12.0 q 12.1 q 12.5 q 10.7 q 21.4 q 11.2 q 14.3 q 13.9 q 13.8 q
21 55.0 q 63.1 t
22 15.1 q
aRecorded at 150 MHz in CDCl3. Chemical shifts (δ) are expressed in ppm.
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provided evidence that the 18,19-lactone carbonyl carbon in 1
was reduced to an acetal methine [δH 4.26 (s, H-18); δC 106.6
(C-18)] in 2, which was confirmed by the key HMBC
correlations (Figure S10, Supporting Information) of H3-21/C-
18, H2-19/C-18, and H-18/C-3. NOE correlations (Figure S11,
Supporting Information) of Hb-19/H-10, Ha-19/H-8, and H-
8/H3-17 suggested that H-8, H-10, and Me-17 are β-oriented.
H-6α and H-6β were designated from NOE correlations with
H3-20 and Ha-9, respectively, while the α-orientation of H-18
was elucidated by a NOE correlation of H-18/Hβ-6. The 13C
NMR data and HRESIMS of notolutesin C (3) revealed a
molecular formula of C22H34O3, which showed 14 mass units
more than 2. The 1H and 13C NMR data (Tables 1 and 3) of 3
closely matched those of 2, apart from the absence of the
oxygenated methyl and the appearance of an oxygenated
methylene [δH 3.71 (quintet, J = 7.2 Hz, Ha-21) and 3.40
(quintet, J = 7.2 Hz, Hb-21); δC 63.1 (C-21)] and a methyl [δH
1.12 (t, J = 7.2 Hz, H3-22); δC 15.1 (C-22)]. Key
1H−1H
COSY correlations (Figure S21, Supporting Information) of
H3-22/H2-21 and HMBC correlations (Figure S21, Supporting
Information) from H2-21 to C-18 suggested that the methoxy
group at C-18 in 2 is replaced by an ethoxy group in 3.
Compounds 3 and 2 might be artifacts arising from compound
1 during the extraction and isolation in the presence of EtOH
and MeOH, respectively. Thus, the structures of 2 and 3 were
determined as depicted.
Notolutesin D (4) was obtained as colorless needles
(MeOH). A molecular formula of C20H32O was established
on the basis of the 13C NMR data and by HRESIMS,
accounting for five indices of hydrogen deficiency. An
examination of the 1H and 13C NMR data (Tables 1 and 3)
showed the structure of 4 to be similar to that of 1. Further
analysis of the NMR data of 4 indicated that the 18,19-lactone
ring of 1 was absent. In contrast, an oxygenated methylene [δH
4.10 (s, H2-18); δC 63.1 (C-18)] and a tertiary methyl [δH 1.09
(s, H3-19); δC 22.2 (C-19)] could be located at C-4 and C-5,
respectively, which were supported by HMBC correlations
(Figure 1) from H2-18 to C-3 and C-5 and from H3-19 to C-4,
C-5, C-6, and C-10, respectively. Key 1H−1H COSY
correlations (Figure 1) of H-3/H2-2/H2-1/H-10 established
the absence of an OH group at C-2 in 4. NOE correlations
(Figure 2) of H-10/H3-19, H3-19/Hβ-6, Hβ-6/H-8, and H-8/
H3-17 were used to determine that these groups are all β-
oriented, while H-12α and H-12β were determined by NOE
correlations with H3-20 and H3-17, respectively. Thus, the
structure of 4 was determined to be as shown.
The HRESIMS of notolutesin E (5) showed a [M + NH4]
+
ion peak at m/z 304.2638 (calcd 304.2635, C20H34ON),
indicating an additional index of hydrogen deficiency when
compared to 4. The 1H and 13C NMR data (Tables 1 and 3) of
5 revealed its structure to be similar to that of 4, with a
noticeable difference being the observation of disubstituted
double-bond resonances [δH 5.78 (m, H-1) and 6.02 (dd, J =
15.0, 5.4 Hz, H-2); δC 126.7 (C-1) and 124.7 (C-2)], which
were supported by 1H−1H COSY correlations of H-10/H-1/H-
2/H-3 (Figure S41, Supporting Information). Thus, the
structure of 5 was determined to be as depicted.
Compound 6 was assigned a molecular formula of C19H26O,
based on its 13C NMR data and HRESIMS, suggesting one
additional index of hydrogen deficiency when compared to 5.
In the 1H NMR spectrum, the olefinic protons at δH 7.31 (d, J
= 6.6 Hz, H-1), 7.20 (d, J = 7.8 Hz, H-2), and 7.24 (d, J = 6.6
Hz, H-3) underwent a large downfield shift, indicating the
presence of a conjugated system. HMBC correlations (Figure
S52, Supporting Information) from H2-18 and H-3 to C-5 (δC
138.8) and from H3-20 and H2-11 to C-10 (δC 148.6)
established that ring A formed an aromatic ring and the methyl
group at C-19 was absent. Thus, 6 was assigned as a 19-nor-
dolabrane diterpenoid, and its structure was determined as
shown.
Notolutesin G (7) was isolated as a colorless oil. Its
molecular formula was determined to be C20H32O3 from the
13C NMR and HRESIMS data, indicating the presence of two
additional oxygen atoms when compared to 4. Comparison of
the 1H and 13C NMR data (Tables 2 and 3) with those of 4
indicated that both compounds have an identical skeleton.
However, their substituents were found to differ only in that C-
2 (δC 67.3) and C-19 (δC 75.5) in 7 are oxygenated. The
HMBC correlations (Figure S63, Supporting Information)
from H-2 [δH 4.45 (t, J = 4.8 Hz)] to C-4 and C-10 and from
Figure 1. 1H−1H COSY (bold) and selected HMBC (arrow)
correlations of 1 and 4.
Figure 2. Key NOESY correlations of 1 and 4.
Figure 3. X-ray crystal structure of compound 1.
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H2-19 [δH 3.35 (d, J = 6.6 Hz) and 2.90 (d, J = 6.6 Hz)] to C-4,
C-5, C-6, and C-10 indicated the presence of OH groups at C-2
and C-19, respectively. NOE correlations of H2-19/H-10, H-
10/H-8, and H-8/H3-17 supported these groups being β-
oriented. H-11α and H-11β were determined by NOEs with
H3-20 and H3-17, respectively. Key NOE correlations of H-2
and H3-20 supported the β-orientation of OH-2 (Figure S64,
Supporting Information). Thus, compound 7 was determined
to be as shown.
Notolutesin H (8) was obtained as colorless crystals
(CHCl3), and its molecular formula, C20H30O2, was established
from the HRESIMS and 13C NMR data, suggesting one more
index of hydrogen deficiency than 7. The 1H and 13C NMR
data (Tables 2 and 3) of these two compounds were closely
comparable, except that the oxymethylenes at C-4 and C-5 in 7
were replaced by an aldehyde [δH 9.64 (s, H-18); δC 194.9 (C-
18)] and a tertiary methyl [δH 1.28 (s, H3-19); δC 34.5 (C-19)]
in 8, respectively. The aldehyde group was assigned at C-4 due
to the HMBC correlations (Figure S74, Supporting Informa-
tion) from H-18 to C-3, C-4, and C-5. Similarly, HMBC
correlations of H3-19/C-4, C-5, C-6, and C-10 confirmed the
location of the methyl group (Me-19) at C-5. Thus, the
structure of 8 was determined as depicted.
Notolutesin I (9) was assigned the molecular formula
C20H30O2 by its
13C NMR data and from the HRESIMS. The
1H and 13C NMR data (Tables 2 and 3) were similar to those
of 7, with the exception of the replacement of the hydroxy
group at C-2 in 9 by a keto group [δC 199.0 (C-2)] in 7. In
addition, the presence of a hydroxy group at C-19 in 7 was
methylated in 9. HMBC correlations (Figure S85, Supporting
Information) were observed from H-10 and H2-18 to C-2 and
from H3-19 to C-4, C-5, C-6, and C-10, respectively. Thus, the
structure of compound 9 was determined as shown.
The molecular formula of notolutesin J (10) was determined
to be C20H30O from the
13C NMR data and by HRESIMS,
suggesting one less oxygen atom present than in 9. Accordingly,
the 1H and 13C NMR data (Tables 2 and 3) of these
compounds were closely comparable, except that the oxy-
methylene [δH 4.39 (s, H2-18) and δC 61.8 (C-18)] in 9 was
found to be replaced by a tertiary methyl [δH 1.06 (s, H3-18)
and δC 32.4 (C-18)] in 10, as confirmed by HMBC correlations
(Figure S96, Supporting Information) from H3-18 to C-3, C-4,
and C-5. Thus, the structure of compound 10 was determined
as shown.
The absolute configuration of compound 1 was established
by comparing its experimental and calculated ECD spectra
predicted by TDDFT (Experimental Section; Figure 4). The
results showed that the experimental and calculated ECD
spectra were in good agreement. From the biosynthetic
standpoint, the absolute configurations of compounds 2−10
were inferred as being the same as that of 1.
Four known diterpenoids, ent-trans-communic acid,10 ent-
trans-communol,11 15,16-bis-nor-13-oxo-8(17),11(E)-labda-
dien-18-ol,12 and (−)-pimara-9(11),15-dien-19-ol,13 were also
isolated. Their structures were identified by comparison with
reported spectroscopic data.
The cytotoxicities of the isolated compounds were evaluated
against PC3 and DU145 human prostate and H1688 and A549
human lung carcinoma cell lines, using the MTT method;16
taxol and adriamycin were used as the positive controls. Only
compound 1 showed cytotoxic activity against the PC3 cell line
(IC50 6.2 μM), but was inactive against the other three tested
cell lines (IC50 > 10 μM).
■ EXPERIMENTAL SECTION
General Experimental Procedures. Melting points were
measured using an X-6 micromelting point apparatus (Tech
Instrument Co., Ltd., Beijing, People’s Republic of China) and are
uncorrected. Optical rotations were obtained using a Gyromat-Hp
polarimeter. UV spectra were acquired with an Agilent 8453E UV−
visible spectroscopy system, with ECD spectra being obtained on a
Chirascan spectropolarimeter (Applied Photophysics Ltd., Leather-
head, UK). IR spectra were recorded using a Nicolet iN 10 Micro
FTIR spectrometer. NMR spectra were recorded on a Bruker Avance
DRX-600 spectrometer operating at 600 (1H) and 150 (13C) MHz,
with TMS as the internal standard. HRESIMS was performed on an
LTQ-Orbitrap XL instrument. HPLC separations were performed on
an Agilent 1200 G1311A quaternary pump equipped with an Agilent
1200 G1322A degasser, an Agilent 1200 G1329B 1260ALS, an Agilent
1200 G1315D DAD detector, and ZORBAX SB-C18 5 μm columns
(9.4 mm × 250 mm). Silica gel (200−300 mesh; Qingdao Haiyang
Chemical Co. Ltd., Qingdao, People’s Republic of China), RP C18
silica gel (40−63 μm, FuJi), Sephadex LH-20 (25−100 μm; Pharmacia
Biotek, Denmark), and MCI gel (CHP20P, 75−150 μm, Mitsubishi
Chemical Industries Ltd.) were used for CC. TLC was carried out with
glass precoated silica gel GF254 plates (Qingdao Haiyang Chemical Co.
Ltd.). The compounds were visualized under UV light and by spraying
with H2SO4−EtOH (1:9, v/v) followed by heating. Implementation of
the MM2 force field in ChemBio3D Ultra software from
CambridgeSoft Corporation (Cambridge, MA, USA, version. 11.0)
was used to calculate the molecular models.
Plant Material. Notoscyphus lutescens was collected in April 2012
from Mount Dawei (1500 m), Yunnan Province, People’s Republic of
China, and authenticated by one of the authors (J.-C.Z.). A voucher
specimen (No. 20120404-42) was deposited at the Department of
Natural Products Chemistry, School of Pharmaceutical Sciences,
Shandong University.
Extraction and Isolation. The air-dried powdered plant material
of N. lutescens (170 g) was extracted with 95% EtOH at room
temperature (3 × 1.5 L, each for 2 weeks). Evaporation of the solvent
provided a dark residue (14.0 g). The EtOH extract was separated by
MCI gel column chromatography (MeOH−H2O, 3:7 to 9:1) to give
four fractions (Frs 1−4). Fr 2 (3.2 g) was chromatographed on a silica
gel column (petroleum ether−acetone, 200:1 to 10:1) to give six
subfractions (Frs 2.a−2.f). Fr 2.a (521 mg) was separated over RP C18
(MeOH−H2O, 6:4 to 9:1) to obtain six fractions (Frs 2.a.1−2.a.6).
Purification of Fr 2.a.3 by preparative HPLC (MeCN−H2O, 78:22, 1.5
mL/min) yielded 6 (5.2 mg, tR 12.3 min) and 10 (4.4 mg, tR 18.2
min). Preparative HPLC (MeCN−H2O, 80:20, 1.5 mL/min) of Fr
2.a.4 yielded ent-trans-communic acid (1.9 mg, tR = 12.9 min), ent-
trans-communol (3.5 mg, tR 18.8 min), and 5 (2.6 mg, tR 22.7 min).
Purification of Fr 2.a.6 by preparative HPLC (MeCN−H2O, 83:17, 1.5
mL/min) yielded 4 (5.7 mg, tR 20.3 min) and (−)-pimara-9(11),15-
dien-19-ol (36.4 mg, tR 21.5 min). Seven fractions (Frs 2.b.1−2.b.7)
Figure 4. Experimental and calculated ECD spectra for compound 1.
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were obtained from Fr. 2.b (747 mg) by using RP C18 (MeOH−H2O,
5:5 to 9:1). Fr 2.b.2 was purified by HPLC (MeCN−H2O, 53:47, 1.5
mL/min) to give 15,16-bis-nor-13-oxo-8(17),11(E)-labdadien-18-ol
(1.3 mg, tR 11.4 min). Preparative HPLC (MeCN−H2O, 67:33, 1.5
mL/min) on Fr 2.b.4 afforded 2 (8.2 mg, tR 17.8 min), 8 (11.7 mg, tR
19.1 min), and 3 (7.3 mg, tR 27.3 min). Fr. 2.c (476 mg) was separated
by RP C18 (MeOH−H2O, 5:5 to 9:1) to obtain a major portion, which
was purified by preparative HPLC (MeCN−H2O, 58:42, 1.5 mL/min)
to afford 1 (1.7 mg, tR 13.8 min), 7 (2.4 mg, tR 15.1 min), and 9 (5.0
mg, tR 19.8 min).
Notolutesin A (1): colorless needles (CHCl3); mp 195−197 °C;
[α]20D −78.1 (c 0.46, MeOH); UV (MeOH) λmax (log ε) 214 (3.96)
nm; ECD (MeOH) λmax (Δε) 222 (−0.83), 257 (+0.18) nm; IR νmax
3483, 2926, 1758, 1461, 1408, and 1290 cm−1; 1H NMR (600 MHz)
and 13C NMR (150 MHz) data (CDCl3), see Tables 1 and 3;
HRESIMS m/z 334.2380 [M + NH4]
+ (calcd for C20H32O3N,
334.2377).
Notolutesin B (2): colorless oil (CHCl3); [α]
20
D −33.7 (c 0.09,
MeOH); UV (MeOH) λmax (log ε) 193 (4.82) nm; ECD (MeOH)
λmax (Δε) 204 (−5.32) nm; IR νmax 3440, 2923, 2859, 1450, 1106, and
1005 cm−1; 1H NMR (600 MHz) and 13C NMR (150 MHz) data
(CDCl3), see Tables 1 and 3; HRESIMS m/z 355.2249 [M + Na]
+
(calcd for C21H32O3Na, 355.2244).
Notolutesin C (3): colorless oil (CHCl3); [α]
20
D −32.0 (c 0.13,
MeOH); UV (MeOH) λmax (log ε) 193 (4.75) nm; ECD (MeOH)
λmax (Δε) 206 (−3.33) nm; IR νmax 3442, 2923, 2860, 1105, and 1002
cm−1; 1H NMR (600 MHz) and 13C NMR (150 MHz) data (CDCl3),
see Tables 1 and 3; HRESIMS m/z 369.2401 [M + Na]+ (calcd for
C22H34O3Na, 369.2400).
Notolutesin D (4): colorless needles (MeOH); mp 187−190 °C;
[α]20D +16.7 (c 0.06, MeOH); UV (MeOH) λmax (log ε) 193 (4.95)
nm; ECD (MeOH) λmax (Δε) 203 (−0.70) nm; IR νmax 3242, 2917,
2855, 1460, 1377, and 997 cm−1; 1H NMR (600 MHz) and 13C NMR
(150 MHz) data (CDCl3), see Tables 1 and 3; HRESIMS m/z
306.2793 [M + NH4]
+ (calcd for C20H36ON, 306.2791).
Notolutesin E (5): colorless oil (CHCl3); [α]
20
D +329.4 (c 0.09,
MeOH); UV (MeOH) λmax (log ε) 271 (4.58) nm; ECD (MeOH)
λmax (Δε) 270 (+19.41) nm; IR νmax 3184, 2973, 2924, 2857, 1462,
and 1132 cm−1; 1H NMR (600 MHz) and 13C NMR (150 MHz) data
(CDCl3), see Tables 1 and 3; HRESIMS m/z 304.2638 [M + NH4]
+
(calcd for C20H34ON, 304.2635).
Notolutesin F (6): colorless oil (CHCl3); [α]
20
D +61.2 (c 0.10,
MeOH); UV (MeOH) λmax (log ε) 206 (4.94), 260 (3.66) nm; ECD
(MeOH) λmax (Δε) 207 (+1.33), 225 (−0.63) nm; IR νmax 3317, 2968,
2927, 1467, and 1377 cm−1; 1H NMR (600 MHz) and 13C NMR (150
MHz) data (CDCl3), see Tables 2 and 3; HRESIMS m/z 271.2057 [M
+ H]+ (calcd for C19H27O, 271.2056).
Notolutesin G (7): colorless oil (CHCl3); [α]
20
D +20.2 (c 0.10,
MeOH); UV (MeOH) λmax (log ε) 194 (4.81) nm; ECD (MeOH)
λmax (Δε) 211 (−2.50) nm; IR νmax 3424, 2925, 2861, 1638, and 1058
cm−1; 1H NMR (600 MHz) and 13C NMR (150 MHz) data (CDCl3),
see Tables 2 and 3; HRESIMS m/z 338.2692 [M + NH4]
+ (calcd for
C20H36O3N, 338.2690).
Notolutesin H (8): colorless needles (CHCl3); mp 200−202 °C;
[α]20D −43.5 (c 0.09, MeOH); UV (MeOH) λmax (log ε) 237 (4.88)
nm; ECD (MeOH) λmax (Δε) 211 (+10.00), 242 (−10.92) nm; IR
νmax 3268, 2968, 2919, 2865, 1696, and 1452 cm
−1; 1H NMR (600
MHz) and 13C NMR (150 MHz) data (CDCl3), see Tables 2 and 3;
HRESIMS m/z 303.2321 [M + H]+ (calcd for C20H31O2, 303.2319).
Notolutesin I (9): colorless oil (CHCl3); [α]
20
D +11.0 (c 0.09,
MeOH); UV (MeOH) λmax (log ε) 246 (4.61) nm; ECD (MeOH)
λmax (Δε) 210 (+2.11), 251 (−2.20), 329 (+0.58) nm; IR νmax 3414,
2922, 1719, 1653, and 1464 cm−1; 1H NMR (600 MHz) and 13C
NMR (150 MHz) data (CDCl3), see Tables 2 and 3; HRESIMS m/z
303.2323 [M + H]+ (calcd for C20H31O2, 303.2319).
Notolutesin J (10): colorless oil (CHCl3); [α]
20
D +18.5 (c 0.11,
MeOH); UV (MeOH) λmax (log ε) 248 (4.79) nm; ECD (MeOH)
λmax (Δε) 205 (+3.36), 249 (−2.99), 327 (+0.94) nm; IR νmax 2921,
2859, 1723, 1663, and 1466 cm−1; 1H NMR (600 MHz) and 13C
NMR (150 MHz) data (CDCl3), see Tables 2 and 3; HRESIMS m/z
287.2371 [M + H]+ (calcd for C20H31O, 287.2369).
X-ray Crystallographic Analysis of Compound 1. C20H28O3,M
= 316.42, orthorhombic system, space group P212121, a = 6.2545(4) Å,
b = 8.1557(6) Å, c = 34.847(2) Å, V = 1777.5(2) Å3, Z = 4, Dcalcd =
1.182 Mg/m3, μ(Mo Kα) = 0.078 mm−1, F(000) = 688, and T =
293(2) K. A crystal of dimensions 0.48 × 0.42 × 0.13 mm3 was
selected for measurements on a Bruker APEX2 CCD area-detector
diffractometer with a graphite monochromator (φ−ω scans), Mo Kα
radiation (λ = 0.710 69 Å). APEX2 Software Suite17 was used for cell
refinement and data reduction. The structure was refined with full-
matrix least-squares calculations on F2 using SHELXL-97.18 A total of
4122 reflections, collected in the θ range 2.34° to 27.63°, yielded 3572
unique reflections (Rint = 0.0285). The final stage converged to R1 =
0.0553 (wR2 = 0.1496) for 4122 observed reflections [with I > 2σ(I)]
and 211 variable parameters, R1 = 0.0472 (wR2 = 0.1409) for all
unique reflections, and goodness-of-fit = 1.008.
Crystallographic data for the structure of 1 have been deposited
with the Cambridge Crystallographic Data Centre as CCDC 996127.
A copy of the data can be obtained free of charge at www.ccdc.cam.ac.
uk/conts/retrieving.html (or from the Cambridge Crystallographic
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44)
1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).
Theory and Calculation Details for Compound 1. Calculations
were performed by the Materials Studio software and the Gaussian 09
program package. The conformational search was performed by
Molecular Dynamical simulations based on the COMPASS force
field15 and by scanning the potential energy surface on the main chain
dihedral angles using the semiempirical AM1. The starting conformer
of compound 1 came from the corresponding X-ray structure (Figure
3). All ground-state geometries were optimized at the B3LYP/6-31G*
level at 298 K, and harmonic frequency analysis was computed to
confirm the minima and, hence, calculation of room-temperature free
energy. Multiple low-energy conformations of compound 1 were
found, and four lower energy conformations were selected to predict
the ECD spectrum of the substance. Electronic excitation energies and
rotational strengths in the gas phase and in methanol were calculated
using TDDFT19,20 at the same level in the velocity formalism for the
first 60 states. The solvent effect of MeOH has been modeled by a
conductor-like screening model for real solvents (COSMO).21,22 The



















where σ is half the bandwidth at 1/e height and ΔEi and Ri are the
excitation energies and rotatory strengths for transition i, respectively.
Here σ = 0.4 eV.
Cytotoxicity Assays. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide, Sigma] assay was used for the test
compounds for cytotoxicity determination in 96-well plates.16 The
cells were plated in 96-well plates for 24 h prior to treatment and were
exposed continuously to different concentrations of the compounds
for 24 h. All of the samples for the cytotoxicity assays were dissolved in
DMSO. Subsequently, 10 μL of MTT (5 mg/mL in phosphate-
buffered saline) was added to each well, and the plates were incubated
at 37 °C under 5% CO2 for 4 h. The absorbance of the solution was
measured at 570 nm on a plate reader (Bio-Rad). IC50 values (the
concentration resulting in 50% inhibition of cell growth) for the test
compounds were calculated from the plotted results, with untreated
cells being set at 100%. The experiments were conducted a minimum
of three times. Taxol and adriamycin were used as the positive
controls, with IC50 values of (0.94, 1.79, 0.85, and 1.04) and (11.74,




1D-NMR, 2D-NMR, HRESIMS, IR, UV, and ECD spectra of
the new compounds 1−10; key HMBC (solid arrows), 1H−1H
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COSY (bold lines), and NOESY (dashed arrows) correlations
for compounds 2, 3, and 5−10; and X-ray data of compound 1
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